Champions Oncology Inc

Research Champions Oncology Inc (CSBR) on Bullrun: market cap USD 89.29M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCSBR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 89.29M
• Financial periodFY2025
• RevenueUSD 56.94M
• Revenue growth13.5%
• Net incomeUSD 4.70M
• Free cash flowUSD 7.00M
• Gross margin50.1%

Valuation Snapshot

latest market cap is USD 89.29M.

About Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies.

Frequently asked questions

What is Champions Oncology Inc's market cap?

Champions Oncology Inc's market capitalization is USD 89.29M.

What does Champions Oncology Inc do?

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States.